Publications en collaboration avec des chercheurs de Hospital Universitario de Basurto (51)

2024

  1. Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus. IMMINENT study

    Neurologia

2023

  1. Planificación familiar en hombres y mujeres con esclerosis múltiple. Análisis del Registro Andaluz (2018-2022)

    Revista de neurologia, Vol. 76, Núm. 12, pp. 377-383

2020

  1. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease

    Neurologia, Vol. 35, Núm. 3, pp. 185-206

  2. FOSMN: A possible TDP-43 proteinopathy to consider in a patient with facial sensory symptoms

    Neurology: Clinical Practice, Vol. 10, Núm. 5, pp. E47-E50

2019

  1. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease

    Medicina Clinica, Vol. 153, Núm. 2, pp. 82.e1-82.e17

  2. Multiple sclerosis: Pregnancy and women's health issues

    Neurologia

2018

  1. Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course 06 Biological Sciences 0604 Genetics 11 Medical and Health Sciences 1109 Neurosciences

    Journal of Neuroinflammation, Vol. 15, Núm. 1

  2. Integrative group-based cognitive rehabilitation efficacy in multiple sclerosis: a randomized clinical trial

    Disability and Rehabilitation, Vol. 40, Núm. 2, pp. 208-216

  3. Seronegative and seropositive autoimmune autonomic ganglionopathy (AAG): Same clinical picture, same response to immunotherapy

    Journal of Neuroimmunology, Vol. 319, pp. 68-70

2017

  1. The influence of posterior visual pathway damage on visual information processing speed in multiple sclerosis

    Multiple Sclerosis, Vol. 23, Núm. 9, pp. 1276-1288

2016

  1. Long-term adherence to IFN beta-1a treatment when using rebismart1device in patients with relapsing-remitting multiple sclerosis

    PLoS ONE, Vol. 11, Núm. 8

  2. Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus

    Neurology: Neuroimmunology and NeuroInflammation, Vol. 3, Núm. 3

  3. Revisión de las novedades del XXXI Congreso ECTRIMS 2015, presentadas en la VIII Reunión Post-ECTRIMS

    Revista de Neurologia, Vol. 62, Núm. 12, pp. 559-569

2015

  1. Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice

    Clinica Chimica Acta, Vol. 438, pp. 67-69

  2. Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis

    Multiple Sclerosis, Vol. 21, Núm. 12, pp. 1498-1512

  3. Consenso español actualizado sobre el uso del natalizumab (Tysabri®)-2013

    Neurologia, Vol. 30, Núm. 5, pp. 302-314

  4. FTY720 attenuates excitotoxicity and neuroinflammation

    Journal of Neuroinflammation, Vol. 12, Núm. 1

  5. Pharmacogenomic study in patients with multiple sclerosis Responders and nonresponders to IFN-β

    Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e154

  6. Review of the novelties from the 2014 ECTRIMS-ACTRIMS joint congress, presented at the 7th post-ECTRIMS meeting (II)

    Revista de Neurologia, Vol. 61, Núm. 6, pp. 271-283

  7. Review of the novelties from the 2014 ectrims-actrims joint congress, presented at the 7th post-ectrims meeting (i)

    Revista de Neurologia, Vol. 61, Núm. 5, pp. 215-224